Valproate-associated dysmyelopoiesis in elderly patients.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 12162682.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Sodium valproate is widely prescribed for patients with epilepsy and psychiatric disorders. Hematologic toxic effects have been largely described in pediatric patients, and dysmyelopoiesis is reported rarely. We describe 2 elderly patients with valproate-associated dysmyelopoiesis and postulate that this particular side effect may be much more common than currently recognized. A correct diagnosis is important for acute patient anagement and for prognostication.
Medical subject headings
- Anticonvulsants
- Myelodysplastic Syndromes
- Valproic Acid